Safety and efficacy of noninvasive ventilation in patients with blunt chest trauma: a systematic review
1 Medical Intensive Care Unit, Respiratory Institute, Cleveland Clinic Foundation, Euclid Avenue, Cleveland, OH 44195, USA
2 Department of Critical Care Medicine, Sunnybrook Health Sciences Centre and University of Toronto, Bayview Avenue, Toronto, ON, M4N 3M5, Canada
3 Interdepartmental Division of Critical Care, University of Toronto and Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Bayview Avenue, Toronto, ON, M4N 3M5, Canada
4 Department of Medicine, University Health Network, Bathhurst Street, Toronto, ON, M5T 2S8, Canada
5 Department of Surgery, Sunnybrook Health Sciences Centre and University of Toronto, Bayview Avenue, Toronto, ON, M4N 3M5, Canada
Critical Care 2013, 17:R142 doi:10.1186/cc12821Published: 22 July 2013
This systematic review looks at the use of noninvasive ventilation (NIV), inclusive of noninvasive positive pressure ventilation (NPPV) and continuous positive pressure ventilation (CPAP), in patients with chest trauma to determine its safety and clinical efficacy in patients with blunt chest trauma who are at high risk of acute lung injury (ALI) and respiratory failure.
We searched the MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials (CENTRAL) databases. Pairs of reviewers abstracted relevant clinical data and assessed the methodological quality of randomized controlled trials (RCTs) using the Cochrane domain and observational studies using the Newcastle-Ottawa Scale.
Nine studies were included (three RCTs, two retrospective cohort studies and four observational studies without a comparison group). There was significant heterogeneity among the included studies regarding the severity of injuries, degree of hypoxemia and timing of enrollment. One RCT of moderate quality assessed the use of NPPV early in the disease process before the development of respiratory distress. All others evaluated the use of NPPV and CPAP in patients with blunt chest trauma after the development of respiratory distress. Overall, up to 18% of patients enrolled in the NIV group needed intubation. The duration of NIV use was highly variable, but NIV use itself was not associated with significant morbidity or mortality. Four low-quality observational studies compared NIV to invasive mechanical ventilation in patients with respiratory distress and showed decreased ICU stay (5.3 to 16 days vs 9.5 to 15 days), complications (0% to 18% vs 38% to 49%) and mortality (0% to 9% vs 6% to 50%) in the NIV group.
Early use of NIV in appropriately identified patients with chest trauma and without respiratory distress may prevent intubation and decrease complications and ICU length of stay. Use of NIV to prevent intubation in patients with chest trauma who have ALI associated with respiratory distress remains controversial because of the lack of good-quality data.